1 2 3 4 5

читать далее ... ion of the antihypertensive efficacy and tolerability of fixed very low-dose penndopril/indapamid combination in patients with mild to moderate hypertension. Vnitr. Lek, 2004, 50 (6), 447-454. 4. Asmar R., London G., O'Rourke M. et al. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. J. Hypertens. Suppl., 2001, 19 (Suppl. 4), S15-S20. 5. de Luca N., Mallion J., O'Rourke M. et al. Regression of left ventricular mass in hypertensive patients treated with penndopril/indapamide as a first-line combination: the REASON echocardiography study. Am. J. Hypertens., 2004, 17, 660667. 6. de Luca N., Asmar R., London G. et al. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapanude in hypertensive subjects. J. Hypertens., 2004, 22 (8), 1623-1630. 7. Mogensen С., Viberti G., Halimi S. et al. Effect of low-dose penndopril/indapamide on albuminuria in diabetes. Preterax in albuminuria regression: PREMIER. Hypertension, 2003, 41, 1063-1071. 8. Dahlof B. The PICXEL study benefits of a low dose combination on left ventricular hypertrophy reduction. XIV European Meeting on Hypertension, Paris, 2004. 9. Dahlof В., Gosse P., Gueret 0. et al. THE P.I.C.X.E.L study: benefits of Preterax on LVH reduction. J. Hypertens., 2004, 22 (suppl. 2), S410, Abstract S9. 10. Gosse P., Dubourg 0., Gueret P et al. Efficacy of very low dose perindopril 2 mg/indapamide 0,625 mg combination on left ventncular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. J. Hum. Hypertens., 2002, 16, 653-659. 11. Laurent S. Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage. J. Hypertens. Suppl., 2003, 21 (SuppL 3), S11-D18. 12. Chalmers J. ADVANCE study: objectives, design and current status. Drugs, 2003, 63 (1), 39-44. 13. Grobbee D. How to ADVANCE prevention of cardiovascular complications in type 2 diabetes. Metabolism, 2003, 52 (8. Suppl. 1), 24-28.Источник: Дупляков Д.В. Клиническая фармакология и терапия.2005. №3. С. 62-64